Standout Papers

SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoh... 2023 2026 202465
  1. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis (2023)
    Yunfeng Shen, Minxuan Xu et al. Metabolism

Immediate Impact

54 standout
Sub-graph 1 of 25

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Emerging nitric oxide gas‐assisted cancer photothermal treatment
2024 Standout
4 intermediate papers

Works of Zhiping Wan being referenced

A biodegradable “Nano-donut” for magnetic resonance imaging and enhanced chemo/photothermal/chemodynamic therapy through responsive catalysis in tumor microenvironment
2021
Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Zhiping Wan 205 54 168 172 18 458
Li Tu 211 34 164 112 24 548
Zhida Shen 206 35 204 113 24 523
Yao Lu 153 31 168 72 14 437
Stefania Porto 251 54 89 160 13 573
Weidong Ni 187 37 157 82 35 568
Guoqing Zuo 181 76 154 126 35 557
Huan Hou 229 23 202 74 30 574
Pamela Maris 239 31 41 87 9 493
Weixi Jiang 128 102 237 50 22 510
Zheng Cai 304 34 133 138 35 515

All Works

Loading papers...

Rankless by CCL
2026